2024 Global Patient Survey

Global Report & Highlights Report Available for Download

The 2024 Global Patient Survey on Lymphomas & CLL provides an in-depth look into the experiences of 11,170 patients and care partners from 79 countries.

This biennial survey delivers crucial insights into the diagnosis, treatment, and challenges faced by those living with lymphoma and CLL, helping to better understand the voices and values of patients and care partners worldwide.

Explore the full 2024 Global Report for a detailed analysis across key categories, or download the Highlights Report for a concise summary of the major findings.

Read the Reports

Explore Lymphoma Coalition’s Latest Research

Insights from the Global Patient Survey on Lymphomas and CLL (GPS)

Lymphoma Coalition has used the results from the Global Patient Survey on Lymphomas and CLL (GPS) to conduct and publish its own research on the patient experience.

It is imperative the issues raised globally by patients through the biennial survey are conveyed to the medical and research communities to improve care moving forward.

Learn More

Browse Resources

Over 4,000 articles on scientific advances in research, treatments & patient care

Find CLINICAL TRIALS & TREATMENTS near you

Health Literacy

The Global Health Literacy Report Card Spotlight on Health Literate Systems and Patient Experience is now live!

Global research conducted by Lymphoma Coalition underscores the significance of patient-doctor communication in healthcare and how communication can either negatively or positively influence patient experience, patient satisfaction and patient understanding across key areas of diagnosis, treatment, and care.

Global Report Card

Read the 2022 Report Card on Lymphomas: Spotlight on the Experience of Patients with Indolent Lymphomas

This report focuses specifically on the experience of those diagnosed with an indolent lymphoma, and the challenges living with a chronic cancer brings.

Lymphoma Coalition Europe

The 2022 Lymphoma Care in Europe is now available!

The focus of this report is to:

► Examine the burden of lymphoma (disease burden and economic impact) in Europe.

► Spotlight the experience of patients with lymphoma and why this experience matters for healthcare decision-making.

► Identify and make recommendations for future lymphoma advocacy initiatives in Europe.

Health Technology Assessment

In the lymphoma treatment landscape, new therapies and emerging biotherapeutic products are transforming cancer care and treatment. Health technology assessment (HTA) systems for medicines and other health technologies differs across countries and regions. There are opportunities and challenges for HTA systems, mechanisms, and processes to become more efficient and promote greater involvement of patient organisations in HTA.